Drug Trial Radar · NCT07570316
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
230
Planned (sponsor's estimate)
Start
Jun 10, 2026
Primary completion
Jun 2028
Study completion May 2030
Sponsor
- Lead sponsor
- argenxargenx (ARGX)
- Sponsor type
- Industry
- First posted
- May 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check whether efgartigimod is safe and well tolerated. It will look at how efgartigimod is distributed and eliminated in the body, how it changes antibody levels, and how the immune system responds to it. The study consists of a part A double-blinded treatment period, a part B treatment/observation period and a part C open-label treatment/observation period. During the part A and part B treatment periods, participants will receive efgartigimod PH20 SC via Prefilled Syringe (PFS) or placebo. During the part C open-label treatment period, participants will receive efgartigimod PH20 SC PFS. Participation in the different parts of the study will depend on the participant's response to treatment. The total study duration for participants ranges from 63 to 135 weeks, depending on the response to treatment. More information can be found here: https://clinicaltrials.argenx.com/vitalithy
Conditions
- Graves' Disease
- Graves Disease
Interventions
Efgartigimod PH20 SCBiological
Subcutaneous injection of Efgartigimod PH20 Via Prefilled Syringe (PFS)
Placebo PH20 SCOther
Subcutaneous injection of placebo PH20 via Prefilled Syringe (PFS)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants who are euthyroid (fT3, fT4, and TSH within normal ranges) off ATDs at week 24 in part ATime frame: Up to 24 weeks (part A)
Locations
35 sites in 3 countries. Site status is shown where the registry gives one.
Profound Research LLC at Tri-City Primary Care
Carlsbad, California · Recruiting
Diabetes Associates Medical Group
Orange, California · Recruiting
Pasadena Clinical Trials
Pasadena, California · Recruiting
Havana Research Institute LLC.
Pasadena, California · Recruiting
San Jose Clinical Trials
San Jose, California · Recruiting
Northeast Florida Endocrine & Diabetes Associates (NEFEDA) - Orange Park Location
Fleming Island, Florida · Recruiting
The Center for Diabetes and Endocrine Care
Fort Lauderdale, Florida · Recruiting
University of Florida Jacksonville College of Medicine
Jacksonville, Florida · Recruiting
Ilumina Medical Research LLC
Kissimmee, Florida · Recruiting
Oceane 7 Medical & Research Center, Inc
Miami, Florida · Recruiting
Johnson County Clin-Trials, Inc.
Lenexa, Kansas · Recruiting
Alliance for Multispecialty Research, LLC
Wichita, Kansas · Recruiting
University of Michigan
Ann Arbor, Michigan · Recruiting
Metro Detroit Endocrinology Center
Dearborn, Michigan · Recruiting
Profound Research
Farmington Hills, Michigan · Recruiting
Truman Medical Center
Kansas City, Missouri · Recruiting
Albany Medical College Community Endocrinology
Albany, New York · Recruiting
Endocrine Associates of West Village PC
New York, New York · Recruiting
Asheville Clinical Research
Asheville, North Carolina · Recruiting
Wake Internal Medicine Consultants
Raleigh, North Carolina · Recruiting
Research Institute of Dallas
Dallas, Texas · Recruiting
Frontier Medical Center - Academy of Diabetes Thyroid and Endocrine
El Paso, Texas · Recruiting
Juno Research
Houston, Texas · Recruiting
Clinic of Endocrinology
Houston, Texas · Recruiting
Tekton Research Irving
Irving, Texas · Recruiting
Biopharma Informatic, LLC
McAllen, Texas · Recruiting
Tekton Research - McKinney
McKinney, Texas · Recruiting
Southern Endocrinology Associates PA
Mesquite, Texas · Recruiting
Consano Clinical Research
Shavano Park, Texas · Recruiting
LLC American Hospital Network
Tbilisi, Georgia · Recruiting
LTD Israeli-Georgian Medical Research Clinic Healthycore
Tbilisi, Georgia · Recruiting
New Hospitals
Tbilisi, Georgia · Recruiting
LLC Todua Clinic
Tbilisi, Georgia · Recruiting
In Vitro Fertilization Center LLC
Tbilisi, Georgia · Recruiting
Queen Elizabeth Hospital (Gateshead Health NHS Foundation Trust)
Gateshead, Tyne and Wear, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.